Hormonal and complimentary treatments for endometriosis: a narrative review
Authors:
- Arissa OnishiAOArissa Onishi
- Cristina Laguna Benetti-PintoCBCristina Laguna Benetti-Pinto
- Daniela Angerame YelaDYDaniela Angerame Yela
Open Access
- 1 June 2025
- journal article
- Published by AME Publishing Company in Gynecology and Pelvic Medicine
- Vol. 8, 12
Abstract
Background and Objective: Endometriosis causes infertility and pain and is associated with detriment to quality of life. The aim is to review hormonal and complementary treatments for pain in women with endometriosis. Up until this review was registered on PROSPERO, no other review had focused exclusively on hormonal and complementary treatments for endometriosis. Prior reviews broadly covered surgical, hormonal, and complementary treatments. Methods: This narrative review was carried out by searching the PubMed, Virtual Health Library and Embase databases for publications in English or Portuguese from 2014 to 2024 about hormonal and complementary treatments. Studies were selected if they focused on endometriosis treatment and a pain scale or quality of life questionnaire were specified. Key Content and Findings: A total of 1,201 publications were identified. After excluding duplications and applying inclusion criteria, 48 studies remained, of which 33 were selected for this review. Dienogest is the most studied therapy, with evidence of its use as first-line treatment. Combined oral pills were superior to placebo and have comparable efficacy to dienogest. Gonadotropin-releasing hormone (GnRH) agonists should be prescribed on a short-term basis, as second-line treatment, considering the side effects, impacts on bone mineral density and cardiovascular health. GnRH antagonists represent a promising therapy, due to dose-dependent hypoestrogenism, minimizing side effects compared to agonists. However, they have not been compared to first-line treatments and so far, should be reserved for cases of treatment failure. Findings suggest that complementary therapies seem to have an important role in adjuvant pain control. However, it is difficult to assess the isolated effect of these therapies because the studies involve multiple concurrent interventions and are not placebo-controlled. Conclusions: Progestins and combined oral contraceptive pills are first-line treatments and GnRH analogues are second-line treatments according to studies with good quality evidence. Complementary treatments lack good quality evidence.Keywords
This publication has 47 references indexed in Scilit:
- Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis: Effects on Bone Mineral DensityReproductive Sciences, 2014
- Yoga e promoção da saúdeCiencia & Saude Coletiva, 2014
- Biopsychosocial correlates of persistent postsurgical pain in women with endometriosisInternational Journal of Gynecology & Obstetrics, 2013
- Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countriesFertility and Sterility, 2011
- Complications after surgery for deeply infiltrating pelvic endometriosisBJOG: An International Journal of Obstetrics & Gynaecology, 2010
- Advances in the management of endometriosis: an update for cliniciansHuman Reproduction Update, 2005
- Quality of life in Brazilian women with endometriosis assessed through a medical outcome questionnaire.2004
- Psychophysiologic Effects of Hatha Yoga on Musculoskeletal and Cardiopulmonary Function: A Literature ReviewThe Journal of Alternative and Complementary Medicine, 2002
- Complementary and Alternative Medicine for Menopausal Symptoms: A Review of Randomized, Controlled TrialsAnnals of Internal Medicine, 2002
- Conventional and alternative treatments for endometriosis.2001